{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:29:14Z","timestamp":1785540554385,"version":"3.56.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Currently, there is a paucity of clinically effective medications for the treatment of diabetic cardiomyopathy (DCM), while the strategy of drug repurposing offers a promising avenue for advancing therapeutic development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The investigation explored the ameliorative effects and uncovered underlying mechanisms of trapidil (TRA), a drug commonly employed in the management of coronary heart disease, on DCM by inhibiting myocardial pyroptosis. Type 1 DCM models were established utilizing C57BL\/6 mice and primary neonatal mouse cardiomyocytes (NMCMs), which were subsequently treated with TRA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Results demonstrated that in DCM mice, TRA significantly enhanced cardiac function, effectively alleviated pathological changes in myocardial tissue, reversed ultrastructural alterations, and reduced pyroptosome formation in myocardial cells. TRA significantly increased the body weight of the mice in the DCM model group, whereas there was no significant alteration in blood glucose levels following TRA treatment. In the myocardial tissue of DCM mice and high-glucose (HG)-treated NMCMs, TRA was found to correct the aberrant expression of key proteins involved in pyroptosis, including cleaved-caspase1, NLRP3, phospho-NF-\u03baB cyclooxygenase-2, interleukin Cleaved-IL-1\u03b2, Cleaved-IL-18, and gasdermin D. Furthermore, TRA effectively curtailed the excessive production of ROS and augmented the mitochondrial membrane potential in NMCMs under the HG environment. Proteomics analysis identified 90 differentially expressed proteins between DCM mice and TRA-treated mice, with glutathione peroxidase 3 (GPX3) emerging as a standout due to its critical role in the cellular antioxidant defense system. Further investigations revealed that the protein and mRNA levels of GPX3, as well as the activated Nrf2 protein levels, were significantly downregulated in the myocardial tissue of DCM mice and HG-treated NMCMs cells. However, these levels were notably upregulated following TRA treatment. Upon knocking down GPX3 mRNA expression using siRNA technology, the anti-pyroptotic effect of TRA in cardiomyocytes was markedly diminished, and the level of activated Nrf2 protein also significantly decreased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, TRA holds potential for improving DCM, with the inhibition of myocardial pyroptosis via the GPX3\/Nrf2 pathway playing a pivotal role. HG-induced Downregulation of the GPX3\/Nrf2 pathway is a critical mechanism underlying pyroptosis in DCM. This pathway can be targeted for the design of DCM-related therapeutics, utilizing the aforementioned signaling mechanisms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1566622","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:13:20Z","timestamp":1748931200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Trapidil attenuates diabetic cardiomyopathy via GPX3\/Nrf2-mediated inhibition of myocardial pyroptosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zihao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/j.1552-4604.1996.tb04756.x","article-title":"Pharmacokinetics of trapidil in patients with chronic liver disease","volume":"36","author":"Berndt","year":"1996","journal-title":"Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"26839","DOI":"10.1074\/jbc.M401907200","article-title":"Determinants of human plasma glutathione peroxidase (GPx-3) expression","volume":"279","author":"Bierl","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. & metabolic Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"G32","DOI":"10.1152\/ajpgi.00064.2011","article-title":"Glutathione peroxidase-3 produced by the kidney binds to a population of basement membranes in the gastrointestinal tract and in other tissues","volume":"301","author":"Burk","year":"2011","journal-title":"Am. J. physiology. Gastrointest. liver physiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"842313","DOI":"10.3389\/fphar.2022.842313","article-title":"Pyroptosis-related inflammasome pathway: a new therapeutic target for diabetic cardiomyopathy","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circulation Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109567","DOI":"10.1016\/j.biopha.2019.109567","article-title":"Icariin modulates carrageenan-induced acute inflammation through HO-1\/Nrf2 and NF-kB signaling pathways","volume":"120","author":"El-Shitany","year":"2019","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrendo.2012.236","article-title":"Coming full circle in diabetes mellitus: from complications to initiation","volume":"9","author":"Harcourt","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1365-2125.1996.04338.x","article-title":"Pharmacokinetics of trapidil, an antagonist of platelet derived growth factor, in healthy subjects and in patients with liver cirrhosis","volume":"42","author":"Harder","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.hyp.31.2.665","article-title":"Trapidil inhibits platelet-derived growth factor-stimulated mitogen-activated protein kinase cascade","volume":"31","author":"Hoshiya","year":"1998","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1254\/fpj.88.95","article-title":"Effect of trapidil on neuropathy in diabetic mice","volume":"88","author":"Inaba","year":"1986","journal-title":"Folia Pharmacol. Jpn."},{"key":"B15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.bcp.2013.07.015","article-title":"Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice","volume":"86","author":"Kim","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/ars.2012.4754","article-title":"The predicted molecular weight of Nrf2: it is what it is not","volume":"18","author":"Lau","year":"2013","journal-title":"Antioxidants & redox Signal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-1-0716-0668-1_9","article-title":"Isolation, culture, and live-cell imaging of primary rat cardiomyocytes","volume":"2158","author":"Leone","year":"2021","journal-title":"Methods Mol. Biol. Clift. N.J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102868","DOI":"10.1016\/j.redox.2023.102868","article-title":"Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis","volume":"67","author":"Li","year":"","journal-title":"Redox Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12967-023-04432-9","article-title":"Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK\/ERK1\/2 pathway and resisted autophagy-related ferroptosis via AMPK\/mTOR pathway in hyperplastic prostate","volume":"21","author":"Li","year":"","journal-title":"J. Transl. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","article-title":"NF-\u03baB in oxidative stress","volume":"7","author":"Lingappan","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2018.08.032","article-title":"AMPK\/PGC1\u03b1 activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis","volume":"129","author":"Liu","year":"2018","journal-title":"Free Radic. Biol. & Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.arr.2023.102182","article-title":"Pyroptosis: mechanisms and links with diabetic cardiomyopathy","volume":"94","author":"Liu","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-023-01747-1","article-title":"Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"791848","DOI":"10.3389\/fphys.2021.791848","article-title":"Pyroptosis and its regulation in diabetic cardiomyopathy","volume":"12","author":"Lu","year":"2022","journal-title":"Front. physiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0090-6980(95)00052-c","article-title":"Effects of trapidil on the PGI2 and TXA2 synthesis in human umbilical veins perfused in vitro","volume":"49","author":"Nieder","year":"1995","journal-title":"Prostaglandins"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e13688","DOI":"10.14814\/phy2.13688","article-title":"A simple antegrade perfusion method for isolating viable single cardiomyocytes from neonatal to aged mice","volume":"6","author":"Omatsu-Kanbe","year":"2018","journal-title":"Physiol. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"B30","doi-asserted-by":"publisher","first-page":"907757","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"L80","DOI":"10.1152\/ajplung.1998.275.1.L80","article-title":"Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells","volume":"275","author":"Rahman","year":"1998","journal-title":"Am. J. physiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circulation Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B35","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1568009617666171002144228","article-title":"Oxidative stress and cancer: the role of Nrf2","volume":"18","author":"Sajadimajd","year":"2018","journal-title":"Curr. cancer drug targets"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/nu11092090","article-title":"Oxidative stress in cardiovascular diseases: still a therapeutic target?","volume":"11","author":"Senoner","year":"2019","journal-title":"Nutrients"},{"key":"B37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/s0008-6363(03)00261-x","article-title":"Trapidil protects ischemic hearts from reperfusion injury by stimulating PKAII activity","volume":"58","author":"Sichelschmidt","year":"2003","journal-title":"Cardiovasc Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.111.00562","article-title":"Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy","volume":"61","author":"Sun","year":"2013","journal-title":"Hypertens. (Dallas, Tex, 1979)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/bph.14601","article-title":"Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy","volume":"177","author":"Sun","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biopha.2018.04.001","article-title":"Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model","volume":"103","author":"T\u00fcrck","year":"2018","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"eabj3859","DOI":"10.1126\/sciimmunol.abj3859","article-title":"NLRP3 inflammasome activation triggers gasdermin D-independent inflammation","volume":"6","author":"Wang","year":"2021","journal-title":"Sci. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3892\/mmr.2018.9699","article-title":"A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti-inflammatory mechanisms","volume":"19","author":"Wang","year":"","journal-title":"Mol. Med. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"967193","DOI":"10.3389\/fimmu.2022.967193","article-title":"Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5411462","DOI":"10.1155\/2022\/5411462","article-title":"Schisandrin A from schisandra chinensis attenuates ferroptosis and NLRP3 inflammasome-mediated pyroptosis in diabetic nephropathy through mitochondrial damage by AdipoR1 ubiquitination","volume":"2022","author":"Wang","year":"","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fendo.2019.00603","article-title":"TLR4\/NF-\u03baB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease","volume":"10","author":"Wang","year":"","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1111\/bph.12983","article-title":"Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e2201899119","DOI":"10.1073\/pnas.2201899119","article-title":"Tumor-polarized GPX3+ AT2 lung epithelial cells promote premetastatic niche formation","volume":"119","author":"Wang","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e18055","DOI":"10.1111\/jcmm.18055","article-title":"Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: activation of the AMPK\/Nrf2 pathway","volume":"28","author":"Xu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.117.029557","article-title":"C1q\/Tumor necrosis factor-related protein-9 regulates the fate of implanted mesenchymal stem cells and mobilizes their protective effects against ischemic heart injury via multiple novel signaling pathways","volume":"136","author":"Yan","year":"2017","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0136649","DOI":"10.1371\/journal.pone.0136649","article-title":"A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes","volume":"10","author":"Yang","year":"2015","journal-title":"PloS one"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/bjp.2008.373","article-title":"Protective action of doxycycline against diabetic cardiomyopathy in rats","volume":"155","author":"Yaras","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11684-021-0881-2","article-title":"Hyperglycemic memory in diabetic cardiomyopathy","volume":"16","author":"Zhan","year":"2022","journal-title":"Front. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10517-021-05217-0","article-title":"Conophylline suppresses angiotensin II-induced myocardial fibrosis in vitro via the BMP4\/JNK pathway","volume":"171","author":"Zhang","year":"2021","journal-title":"Bull. Exp. Biol. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1566622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:13:21Z","timestamp":1748931201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1566622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":50,"alternative-id":["10.3389\/fphar.2025.1566622"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1566622","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1566622"}}